{
    "organizations": [],
    "uuid": "096d3d3d06d1ccc39d454cf2157bace9f38727fa",
    "author": "Reuters Editorial",
    "url": "https://www.reuters.com/article/brief-ablynx-announces-option-exercise-b/brief-ablynx-announces-option-exercise-by-sanofi-to-license-two-additional-target-combinations-idUSFWN1Q6038",
    "ord_in_thread": 0,
    "title": "BRIEF-Ablynx Announces Option Exercise By Sanofi To License Two Additional Target Combinations​",
    "locations": [],
    "highlightText": "",
    "language": "english",
    "persons": [],
    "text": "Feb 16 (Reuters) - ABLYNX NV:\n* ABLYNX ANNOUNCES OPTION EXERCISE BY SANOFI FOR TWO ADDITIONAL MULTI-SPECIFIC NANOBODY PRODUCT CANDIDATES\n* SANOFI HAS EXERCISED ITS OPTION TO LICENSE TWO ADDITIONAL TARGET COMBINATIONS​\n* ‍OPTION AS PART OF RESEARCH COLLABORATION SIGNED IN JULY 2017​\n* ‍SANOFI GAINS EXCLUSIVE GLOBAL RIGHTS TO TWO ADDITIONAL MULTI-SPECIFIC NANOBODIES AGAINST SELECTED TARGETS​\n* ‍IN RETURN SANOFI WILL PAY ABLYNX EXERCISE FEES TOTALLING EUR 13 MILLION PLUS ADDITIONAL RESEARCH FUNDING​\n* ‍ABLYNX HAS ALREADY RECEIVED AN UPFRONT PAYMENT TOTALLING EUR 23 MILLION\n* ‍RECEIVED AN UPFRONT PAYMENT IS TOGETHER WITH RESEARCH FUNDING UNDER THIS COLLABORATION​\n* ‍SANOFI WILL BE RESPONSIBLE FOR DEVELOPMENT, MANUFACTURING AND COMMERCIALISATION OF ANY PRODUCTS RESULTING FROM THIS AGREEMENT​\n* ‍ABLYNX WILL BE ELIGIBLE TO RECEIVE DEVELOPMENT, REGULATORY AND COMMERCIAL MILESTONE PAYMENTS OF UP TO EUR 2.4 BILLION PLUS TIERED ROYALTIES​ Source text for Eikon: Further company coverage: (Gdynia Newsroom)\n ",
    "published": "2018-02-16T15:20:00.000+02:00",
    "crawled": "2018-02-17T14:26:21.003+02:00",
    "highlightTitle": "",
    "preprocessed_text": [
        "feb",
        "reuters",
        "ablynx",
        "nv",
        "ablynx",
        "announces",
        "option",
        "exercise",
        "sanofi",
        "two",
        "additional",
        "nanobody",
        "product",
        "candidate",
        "sanofi",
        "exercised",
        "option",
        "license",
        "two",
        "additional",
        "target",
        "part",
        "research",
        "collaboration",
        "signed",
        "july",
        "gain",
        "exclusive",
        "global",
        "right",
        "two",
        "additional",
        "nanobodies",
        "selected",
        "return",
        "sanofi",
        "pay",
        "ablynx",
        "exercise",
        "fee",
        "totalling",
        "eur",
        "million",
        "plus",
        "additional",
        "research",
        "already",
        "received",
        "upfront",
        "payment",
        "totalling",
        "eur",
        "million",
        "upfront",
        "payment",
        "together",
        "research",
        "funding",
        "responsible",
        "development",
        "manufacturing",
        "commercialisation",
        "product",
        "resulting",
        "eligible",
        "receive",
        "development",
        "regulatory",
        "commercial",
        "milestone",
        "payment",
        "eur",
        "billion",
        "plus",
        "tiered",
        "source",
        "text",
        "eikon",
        "company",
        "coverage",
        "gdynia",
        "newsroom"
    ]
}